Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?

Creative Commons License

Balli M., Tasolar H., Cetin M., Hatem E., ÇAĞLIYAN Ç. E., Seker T., ...More

JOURNAL OF CARDIOLOGY, vol.67, pp.327-330, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 67
  • Publication Date: 2016
  • Doi Number: 10.1016/j.jjcc.2015.09.018
  • Journal Name: JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.327-330
  • Çukurova University Affiliated: Yes

Abstract

Background: Contrast-induced nephropathy (CIN) is an iatrogenic problem in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). Atrial fibrillation (AF) may also contribute to impaired kidney function. Several factors may contribute to the development of CIN. In patients with STEMI, concomitant AF is associated with higher in-hospital/follow-up mortality and morbidity. Therefore, we aimed to investigate the relationship between AF and CIN developments.